HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Doxorubicin(6-maleimidocaproyl)hydrazone

HCID 9576002
New reaction
Print
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
151038-96-9
Standard SMILES
COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)CC(O)(/C(CO)=N/NC(=O)CCCCCN1C(=O)C=CC1=O)CC3OC1CC(N)C(O)C(C)O1
InChIKey
OBMJQRLIQQTJLR-JRZNSJKLSA-N
Molecular formula
C37H42N4O13
Average molar mass
750.7 g/mol
Monoisotopic mass
750.27483741

Overview

Aldoxorubicin is a 6-maleimidocaproyl hydrazone derivative prodrug of the anthracycline antibiotic doxorubicin (DOXO-EMCH) with antineoplastic activity. Following intravenous administration, aldoxorubicin binds selectively to the cysteine-34 position of albumin via its maleimide moiety. Doxorubicin is released from the albumin carrier after cleavage of the acid-sensitive hydrazone linker within the acidic environment of tumors and, once located intracellularly, intercalates DNA, inhibits DNA synthesis, and induces apoptosis. Albumin tends to accumulate in solid tumors as a result of high metabolic turnover, rapid angiogenesis, hypervasculature, and impaired lymphatic drainage. Because of passive accumulation within tumors, this agent may improve the therapeutic effects of doxorubicin while minimizing systemic toxicity. (NCIt).

Names & identifiers

Preferred name
Doxorubicin(6-maleimidocaproyl)hydrazone
IUPAC
N-[(E)-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamide
English name
doxorubicin(6-maleimidocaproyl)hydrazone
Molecular formula
C37H42N4O13
Molecular weight
750.75

Names & synonyms

Doxorubicin(6-maleimidocaproyl)hydrazoneMC-DoxhznRefChem:135732N-[(E)-[1-[4-(4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-3,4-dihydro-1H-tetracen-2-yl]-2-hydroxyethylidene]amino]-6-(2,5-dioxopyrrol-1-yl)hexanamideDoxorubicin-hydrazone-caproyl-maleimide2,5-Dihydro-2,5-dioxo-1H-pyrrole-1-hexanoic acid (1-(4-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-1,2,3,4,6,11-hexahydro-2,5,12-trihydroxy-7-methoxy-6,11-dioxo-2-naphthacenyl)-2-hydroxyethylidene)hydrazide, (2S-cis)-CHEBI:231680INNO-206DOXO-EMCHAldoxorubiciDoxorubicin-EMCHMC DOXHZN,MCDOXHZN
Show more names
INNO-206 (Aldoxorubicin)DOXO-EMCHDOXORUBICIN-EMCHINNO206INNO 206ALDOXORUBICIN

Properties

Computed structural properties

XLogP
1.3
Topological polar surface area
268 Ų
Hydrogen bond donors
7
Hydrogen bond acceptors
15
Rotatable bonds
12
Heavy atoms
54
Formal charge
0
Complexity
1,510

Physicochemical properties

Density
1.6 · 1.60
solubility
Soluble in DMSO
pka
7.38 · 7.38±0.60(Predicted)
FDA UNII
28 MV4IM0B · C28MV4IM0B
Safety Statements
23 · 23-24/25

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

Safety data

safety_code
23-24/25

Chemistry & industry

Applications

UsesDoxorubicin-hydrazone-caproyl-maleimide is an albumin-binding prodrug of doxorubicin and a promising clinical candidate for the treatment of a broad range of solid tumors

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes

Database identifiers

CAS
151038-96-9
PubChem CID
9576002
ChEBI
CHEBI:231680
Nikkaji
J3.201.486K